Université de Montréal

Deciphering the Origins of P1-Induced Power Losses in CIGS Modules Through Hyperspectral Luminescence (2020) Quiroz COR, Dion-Bertrand LI, Brabec C, Müller J, Orgassa K Journal article Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS (2019) Chao CC, Gutierrez-Vazquez C, Rothhammer V, Mayo L, Wheeler MA, Tjon EC, Zandee SEJ, et al. Journal article Luminescence and Light-Driven Energy and Electron Transfer from an Exceptionally Long-Lived Excited State of a Non-Innocent Chromium(III) Complex (2019) Treiling S, Wang C, Foerster C, Reichenauer F, Kalmbach J, Boden P, Harris JP, et al. Journal article TESS first look at evolved compact pulsators Discovery and asteroseismic probing of the g-mode hot B subdwarf pulsator EC 21494-7018 (2019) Heber U, Charpinet S, Brassard P, Fontaine G, Van Grootel V, Zong W, Giammichele N, et al. Journal article National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism (2019) Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, et al. Journal article, Letter THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al. Conference contribution ICAR: endoscopic skull-base surgery (2019) Wang EW, Zanation AM, Gardner PA, Schwartz TH, Eloy JA, Adappa ND, Bettag M, et al. Journal article Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias (2019) Stanek M, Picard LP, Schmidt M, Kaindl J, Hübner H, Bouvier M, Weikert D, Gmeiner P Journal article Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 (2019) Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutierrez-Vazquez C, et al. Journal article Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019) Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, et al. Conference contribution